Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
27 04 2022
Historique:
pubmed: 1 3 2022
medline: 30 4 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

Human papillomavirus (HPV) circulating tumor DNA (HPV ctDNA) was proposed as a biomarker for the detection and disease monitoring of HPV-related cancers. One hundred eighty plasma samples obtained from women diagnosed with HPV16-positive cervical cancer (CC) (

Identifiants

pubmed: 35225653
doi: 10.1128/spectrum.01480-21
pmc: PMC9045285
doi:

Substances chimiques

Biomarkers 0
DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0148021

Références

Br J Cancer. 2003 May 6;88(9):1388-93
pubmed: 12778066
Clin Cancer Res. 2019 Aug 1;25(15):4682-4690
pubmed: 31088830
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
Cell Oncol (Dordr). 2017 Oct;40(5):521-527
pubmed: 28748500
Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):415-22
pubmed: 8220085
Cancer Biomark. 2017;19(2):129-136
pubmed: 28387659
Sex Transm Infect. 2019 Mar;95(2):83-86
pubmed: 29934358
Ann Oncol. 2019 Aug 1;30(8):1335-1343
pubmed: 31185496
J Clin Oncol. 2020 Apr 1;38(10):1050-1058
pubmed: 32017652
Int J Cancer. 2005 Jan 20;113(3):483-9
pubmed: 15455386
J Virol Methods. 2002 Oct;106(1):61-70
pubmed: 12367730
Clin Cancer Res. 2018 May 1;24(9):2194-2202
pubmed: 29420222
J Clin Oncol. 2013 Jul 20;31(21):2708-15
pubmed: 23775966
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
ESMO Open. 2021 Jun;6(3):100154
pubmed: 34022731
JNCI Cancer Spectr. 2019 Jan 07;2(4):pky045
pubmed: 31360870
J Immunol Methods. 2006 Feb 20;309(1-2):200-4
pubmed: 16406059
Int J Epidemiol. 2017 Jun 1;46(3):924-938
pubmed: 27789668
J Clin Microbiol. 2010 Jan;48(1):143-9
pubmed: 19864475
Cancer Cytopathol. 2018 Jul;126(7):447-460
pubmed: 29797691
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376197
Clin Chem. 2005 Oct;51(10):1845-53
pubmed: 16099939
Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):3-6
pubmed: 11815394
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
Cancer Lett. 2003 Dec 30;202(2):231-9
pubmed: 14643453
J Clin Oncol. 2015 Oct 10;33(29):3235-42
pubmed: 26351338
Cancers (Basel). 2020 Oct 15;12(10):
pubmed: 33076524
Br J Cancer. 2017 Sep 5;117(6):876-883
pubmed: 28809864
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
J Mol Diagn. 2018 Nov;20(6):883-892
pubmed: 30165204
Br J Cancer. 2018 Aug;119(3):381-386
pubmed: 30026613
J Clin Virol. 2019 May;114:32-36
pubmed: 30913520
Int J Cancer. 2014 Nov 15;135(10):2453-61
pubmed: 24729277
Int J Mol Sci. 2018 Oct 24;19(11):
pubmed: 30352977
Cancer. 2021 Mar 15;127(6):850-864
pubmed: 33270909
J Immunol Methods. 2001 Jul 1;253(1-2):153-62
pubmed: 11384677
Comput Struct Biotechnol J. 2018 Oct 09;16:370-378
pubmed: 30364656
Oral Oncol. 2018 Mar;78:137-144
pubmed: 29496041
Cancer Prev Res (Phila). 2019 Oct;12(10):689-700
pubmed: 31420362
J Med Virol. 2005 Mar;75(3):435-9
pubmed: 15648077
J Clin Virol. 2004 Nov;31(3):204-9
pubmed: 15465413
Am J Obstet Gynecol. 2003 Jan;188(1):49-55
pubmed: 12548195
Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):423-31
pubmed: 8220086
Clin Cancer Res. 2017 Nov 15;23(22):6856-6862
pubmed: 28899967
J Clin Microbiol. 2016 Aug;54(8):2031-8
pubmed: 27225411
Front Oncol. 2020 Apr 17;10:505
pubmed: 32363162
J Pathol Clin Res. 2016 Jun 28;2(4):201-209
pubmed: 27917295
PLoS One. 2020 Feb 6;15(2):e0224001
pubmed: 32027658
Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):683-9
pubmed: 25623733
EBioMedicine. 2020 Dec;62:103123
pubmed: 33248371
J Clin Oncol. 2015 Mar 10;33(8):877-84
pubmed: 25667279
Cancer. 2016 May 15;122(10):1544-51
pubmed: 26989832
CA Cancer J Clin. 2020 Sep;70(5):321-346
pubmed: 32729638
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1874-9
pubmed: 17855708
Clin Cancer Res. 2021 Nov 1;27(21):5869-5877
pubmed: 34210686
Int J Cancer. 2016 Jul 1;139(1):85-98
pubmed: 26529033

Auteurs

Luisa Galati (L)

International Agency for Research on Cancer, Lyon, France.

Jean-Damien Combes (JD)

International Agency for Research on Cancer, Lyon, France.

Florence Le Calvez-Kelm (F)

International Agency for Research on Cancer, Lyon, France.

Sandrine McKay-Chopin (S)

International Agency for Research on Cancer, Lyon, France.

Nathalie Forey (N)

International Agency for Research on Cancer, Lyon, France.

Mathis Ratel (M)

International Agency for Research on Cancer, Lyon, France.

James McKay (J)

International Agency for Research on Cancer, Lyon, France.

Tim Waterboer (T)

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lea Schroeder (L)

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Gary Clifford (G)

International Agency for Research on Cancer, Lyon, France.

Massimo Tommasino (M)

International Agency for Research on Cancer, Lyon, France.

Tarik Gheit (T)

International Agency for Research on Cancer, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH